Update on the management of febrile neutropenia in hematologic patients

Febrile neutropenia is a common complication in patients with hematologic malignancies receiving chemotherapy, and is associated with high morbidity and mortality. Infections caused by multidrug-resistant bacteria represent a therapeutic challenge in this high-risk patient population, since inadequa...

Descripción completa

Detalles Bibliográficos
Autores principales: Escrihuela-Vidal, Francesc, Laporte, Júlia, Albasanz-Puig, Adaia, Gudiol, Carlota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2019
Materias:
Update on the Infection of the Immunocompromised Patient
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755372/
https://www.ncbi.nlm.nih.gov/pubmed/31475812
_version_ 1783453219953836032
author Escrihuela-Vidal, Francesc
Laporte, Júlia
Albasanz-Puig, Adaia
Gudiol, Carlota
author_facet Escrihuela-Vidal, Francesc
Laporte, Júlia
Albasanz-Puig, Adaia
Gudiol, Carlota
author_sort Escrihuela-Vidal, Francesc
collection PubMed
description Febrile neutropenia is a common complication in patients with hematologic malignancies receiving chemotherapy, and is associated with high morbidity and mortality. Infections caused by multidrug-resistant bacteria represent a therapeutic challenge in this high-risk patient population, since inadequate initial empirical antibiotic treatment can seriously compromise prognosis. Besides, reducing antimicrobial exposure is a cornerstone in the fight against resistance.
format Online
Article
Text
id pubmed-6755372
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sociedad Española de Quimioterapia
record_format MEDLINE/PubMed
spelling pubmed-67553722019-10-04 Update on the management of febrile neutropenia in hematologic patients Escrihuela-Vidal, Francesc Laporte, Júlia Albasanz-Puig, Adaia Gudiol, Carlota Rev Esp Quimioter Update on the Infection of the Immunocompromised Patient Febrile neutropenia is a common complication in patients with hematologic malignancies receiving chemotherapy, and is associated with high morbidity and mortality. Infections caused by multidrug-resistant bacteria represent a therapeutic challenge in this high-risk patient population, since inadequate initial empirical antibiotic treatment can seriously compromise prognosis. Besides, reducing antimicrobial exposure is a cornerstone in the fight against resistance. Sociedad Española de Quimioterapia 2019-09-01 2019 /pmc/articles/PMC6755372/ /pubmed/31475812 Text en © The Author 2019 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Update on the Infection of the Immunocompromised Patient
Escrihuela-Vidal, Francesc
Laporte, Júlia
Albasanz-Puig, Adaia
Gudiol, Carlota
Update on the management of febrile neutropenia in hematologic patients
title Update on the management of febrile neutropenia in hematologic patients
title_full Update on the management of febrile neutropenia in hematologic patients
title_fullStr Update on the management of febrile neutropenia in hematologic patients
title_full_unstemmed Update on the management of febrile neutropenia in hematologic patients
title_short Update on the management of febrile neutropenia in hematologic patients
title_sort update on the management of febrile neutropenia in hematologic patients
topic Update on the Infection of the Immunocompromised Patient
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755372/
https://www.ncbi.nlm.nih.gov/pubmed/31475812
work_keys_str_mv AT escrihuelavidalfrancesc updateonthemanagementoffebrileneutropeniainhematologicpatients
AT laportejulia updateonthemanagementoffebrileneutropeniainhematologicpatients
AT albasanzpuigadaia updateonthemanagementoffebrileneutropeniainhematologicpatients
AT gudiolcarlota updateonthemanagementoffebrileneutropeniainhematologicpatients

Ejemplares similares